← FDA DRUG APPROVALS

FDA NDA · NDA012772

HALDRONE

Sponsor: LILLY

APPLICATION
NDA012772
TYPE
NDA
ORIGINAL APPROVAL
1961-04-17
LATEST ACTION
1997-01-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HALDRONEDiscontinued
PARAMETHASONE ACETATE 2MG · TABLET · ORAL
HALDRONEDiscontinued
PARAMETHASONE ACETATE 1MG · TABLET · ORAL

Approval history

1997-01-09Labeling · Supplement 9AP
1997-01-09Labeling · Supplement 8AP
1986-05-27Labeling · Supplement 7AP
1980-03-19Labeling · Supplement 5AP
1977-08-22Labeling · Supplement 4AP
1961-04-17Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →